We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

GAMA Healthcare Presents World's First Portable Isolation Room at MEDICA 2021

By HospiMedica International staff writers
Posted on 15 Nov 2021

GAMA Healthcare Ltd. (Hertfordshire, UK) presented the world's first portable isolation room at the MEDICA 2021 international trade fair held on November 15-18 in Düsseldorf, Germany.

GAMA recently announced the international launch of Rediroom, the world’s first portable isolation solution, which is close to receiving its 400th order and has been successfully adopted by NHS hospitals. Rediroom, launched in 2020, is a mobile cart that expands into a HEPA air-filtered isolation room with hands-free entry in five minutes, providing a flexible solution to increasing isolation capacity in response to outbreaks of infection, suspected or unconfirmed infections, and the ability to isolate patients anywhere, including multi-occupancy wards. This reduces the risk of hospital acquired infections (HAIs) that are spread through droplet and direct contact, including norovirus, seasonal flu, C. diff, and Methicillin resistant Staphylococcus aureus (MRSA).


Image: Rediroom (Photo courtesy of GAMA Healthcare Ltd.)
Image: Rediroom (Photo courtesy of GAMA Healthcare Ltd.)

Isolation of infected or colonized patients is a measure utilized to reducing transmission of microorganisms between patients. Reducing transmission (via increased isolation capacity) can be linked to reducing the risk of patients acquiring HAIs. Rediroom is designed to isolate against diseases spread through droplet and direct contact, rather than through aerosol, meaning that the protection provided by Rediroom is most effective for diseases such as norovirus, seasonal flu, C. diff, and MRSA. Following initial sales to hospitals in Japan, GAMA has now launched the product internationally into further key geographies across Europe, MEA, Asia, the Americas and Oceania, and is in discussions with a number of potential partners.

“The reception to Rediroom from the hospitals using it, and from those who have evaluated the product, has been highly positive,” said Guy Braverman, Joint CEO, GAMA Healthcare. “The use of the product to date has provided further validation that Rediroom can help change the way that we approach infection prevention, protect patients and hospital staff from the risk of HAIs, and has the potential to do so in other healthcare systems as well.”

Related Links:
GAMA Healthcare Ltd. 


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Acute Care Scale
PH-740

Latest Critical Care News

Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time

Wearable Multiplex Biosensors Could Revolutionize COPD Management

New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias